Healthcare Insights

Prefilled Syringes Market Set to Surpass USD 24.91 Billion by 2033

The global prefilled syringes market value stood at USD 7.28 billion in 2023 and it is predicted to rise to USD 24.91 billion by 2033 with a solid CAGR of 13.09% from 2024 to 2033. The prefilled syringes make injections accurate, easy, and safe for, both, doctors and patient. Pre-filled syringes have is one of the fastest- growing selection for the medication of unit dose, as the pharmaceutical industry seeks new and more accessible medicine delivery styles.

In addition, pharmaceutical companies can get benefit by saving the cost of vials. Pharmaceutical key players are suitable to minimize medicine waste and increase product life span, while patients are suitable to self- administer injectable medicines at their home rather of the hospital. In addition, re-filled syringes have also stayed employed across a wide range of therapeutic sectors, similar as blood instigations, vaccines, and remedial proteins.

Excluding dosing errors and ease of use are two of the topmost advantages of pre-filled syringes. Accordingly, the discrimination advantages handed by prefilled syringes above traditional syringes are leading to the increased relinquishment and contributing to the global market growth.

Prefilled Syringes Market Highlights:

  • In 2023, North America led the global prefilled syringes market, capturing the largest share of 33%.
  • The disposable segment was the dominant type in the market, holding a 92% share in 2023, and is expected to see the highest growth rate during the forecast period.
  • Within distribution channels, hospitals accounted for the largest market share of 52% in 2023.
  • The mail order pharmacies segment is projected to experience the fastest growth rate throughout the forecast period.
  • In terms of material, glass dominated the market, securing a 52% share in 2023.
  • For applications, vaccines and immunizations held the largest share at 26% in 2023.
  • The oncology segment is anticipated to achieve the fastest compound annual growth rate (CAGR) from 2024 to 2033.

Get the Sample Pages of Report for More Understanding@  https://www.visionresearchreports.com/report/sample/37704

Prefilled Syringe Market Dynamics

DriverRising target complaint population

Prefilled syringes are substantially used for the treatment of chronic diseases, similar as diabetes, heart conditions, and autoimmune conditions, which bear patients to self-administer specifics. As a result, the adding prevalence and frequency of chronic and life conditions across the globe is a major factor contributing to the growth of the prefilled syringes market. Also, there’s a growing demand for self-injection equipments, considering the convenience and safety associated with their use.

Restraint: Dearth of prefilled syringes with intertwined safety features

Prefilled syringes give better safety of patient by diminishing the potential for unintended needle sticks and poisonous products exposure that can do while drawing drug from vials. In similar patients, the defiled needle of prefilled syringes can lead to blood- borne infections, similar as HIV and HCV. In addition, the partial prefilled syringes market presence with intertwined safety features, due to their challenging and expensive manufacturing procedure, is a major concern in the market. Still, this trend is anticipated to change in the coming times, as the healthcare market is laying lesser emphasis on reducing the rate of needle stick injuries, which, in turn, is paving the way for the development of safety prefilled hypes.

OpportunityGrowing healthcare structure across arising markets

Emerging economies will continue to suffer from inadequate healthcare backing, which negatively affects access to quality, healthcare, and, eventually, the health status of citizens. According to the World Bank, roughly 400 million people lacks access to essential healthcare services, substantially in Africa and South Asia. Likewise, accelerating medical affectation, the cost of medical treatments and an advanced frequency of non-communicable life- related conditions similar as diabetes, cancer, or cardiac arrest, have rebounded in funding gaps.

According Geneva Association report, in the last 20 years, the share of the aggregate global healthcare expenditure in GDP has raised from about 8% to nearly 10%, or an estimated US$8000 billion per year, which is boosted by the expanding treatment options, medical treatment accelerating cost and adding client demands. Also, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will nearly triple to USD 24 trillion by 2040 with upper-middle- income countries are estimated to show the fastest increase at a normal of5.3% per time. This growth could be attributed to uninterrupted growth in GDP and the rise of the middle class and government spending.

Challenge: Availability of cheaper alternatives

Traditionally, injectable were painful and invasive in nature, which was the major concern for patients to prefer medicine delivery alternate routes, such as topical, oral, and nasal. In addition, among the various routes of medicine delivery, the oral route is the most preferred as it’s easy to use, accessible, cost-effective, safe, and respectable. Due to the above mentioned factors, the adoption of indispensable medicine delivery technologies is adding across the globe. Like, cost-effective delivery styles development for insulin, alternate, similar as Medtronic’s Veo insulin and Pfizer’s Exubera pump, is restraining the usage of injectable insulin. Presently, insulin is substantially administered via injections, and therefore, injections of insulin form a significant market for injectable medicine delivery technologies. Still, the arrival of inhalable insulin is anticipated to significantly impact the growth of this market as nasal medicine delivery is pain-free and largely patient biddable.

Regional Analysis

In 2023, the North American market for prefilled syringes held a 33% share. This region emphasizes the prevention of needlestick injuries among healthcare professionals, leading to a growing use of prefilled syringes equipped with needle guards. The CDC’s endorsement of prefilled syringes for vaccine administration—due to their effectiveness in preserving vaccine potency and saving time—further supports market expansion.

Europe leads the global prefilled syringes market, driven by a strong preference for these devices to minimize needle-related injuries. Government policies and the activities of major market players are promoting the adoption of single-use medical products, which is anticipated to accelerate market growth.

The Asia-Pacific market is poised for substantial growth, supported by numerous facilities approved by the FDA, TGA, and EMA. The region’s expanding economy, large and growing population, and rising prevalence of chronic conditions are expected to fuel this market’s development.

Top Manufactures in Prefilled Syringes Market

1. BD (Becton, Dickinson and Company)

2. Gerresheimer AG

3. SCHOTT Pharma AG

4. Stevanato Group

5. Nipro Corporation

6. Terumo Corporation

7. West Pharmaceutical Services, Inc.

8. Fresenius Kabi

9. Catalent, Inc.

10. Aptar Pharma

Ask here for more customization study@ https://www.visionresearchreports.com/report/customization/37704

Recent Industry News

Government Support in Prefilled Syringes Market 

Government support significantly influences the prefilled syringes market through regulatory, financial, and policy measures. Agencies such as the FDA, EMA, and TGA establish rigorous approval processes that ensure the safety and efficacy of prefilled syringes, fostering innovation and market growth. Streamlined regulations and clear guidelines not only enhance market confidence but also facilitate the introduction of advanced syringe designs, such as those with needle guards. Additionally, government funding and grants for research and development play a crucial role in advancing technology and reducing production costs, further driving market expansion.

Furthermore, healthcare policies and public health campaigns that promote the use of prefilled syringes contribute to market growth by increasing their adoption in clinical settings. Policies aimed at improving patient safety and reducing healthcare costs often support the use of single-use devices, which can lead to greater demand for prefilled syringes. Economic incentives, such as tax breaks for manufacturers, also help lower production costs, making these devices more accessible. Overall, government support not only stabilizes and stimulates the prefilled syringes market but also ensures broader implementation and integration into healthcare practices.

Read More@ Nanomedicine Market

Prefilled Syringes Market Segmentation:

By Type

By Material

By Application

By Distribution Channel

By Region

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/37704

You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308

Web: https://www.visionresearchreports.com/

Blog: https://www.novaoneadvisor.com/

Exit mobile version